No abstract available
Keywords:
eluxadoline; hepatic impairment; irritable bowel syndrome; pharmacokinetics; safety.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Aged
-
Aged, 80 and over
-
Female
-
Gastrointestinal Agents / adverse effects
-
Gastrointestinal Agents / blood
-
Gastrointestinal Agents / pharmacokinetics*
-
Gastrointestinal Agents / therapeutic use
-
Humans
-
Imidazoles / adverse effects
-
Imidazoles / blood
-
Imidazoles / pharmacokinetics*
-
Imidazoles / therapeutic use
-
Liver Diseases / blood
-
Liver Diseases / metabolism*
-
Male
-
Middle Aged
-
Phenylalanine / adverse effects
-
Phenylalanine / analogs & derivatives*
-
Phenylalanine / blood
-
Phenylalanine / pharmacokinetics
-
Phenylalanine / therapeutic use
-
Treatment Outcome
-
Young Adult
Substances
-
Gastrointestinal Agents
-
Imidazoles
-
eluxadoline
-
Phenylalanine